Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Angiogenesis, Pathologic

rosiglitazone has been researched along with Angiogenesis, Pathologic in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (21.43)29.6817
2010's10 (71.43)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Hermawan, A; Putri, H1
Chen, C; Huang, G; Lan, J; Li, M; Lu, Y; Mo, X; Na, F; Tong, R; Xue, J; Yin, L1
Chen, AM; Cheng, P; Du, Y; Gong, C; Guo, FJ; Liao, H; Qin, L; Ren, Y; Xu, F1
Fu, J; Huang, H; Huang, Z; Liu, R; Liu, Y; Rui, M; Wang, Z1
Fu, J; Fu, T; Huang, H; Liu, Y; Rui, M1
Kumar, H; Mishra, M; Tripathi, K; Vijay, SK1
Dong, YW; Wang, XP; Wu, K1
Higuchi, A; Ohashi, K; Ouchi, N; Shibata, R; Sono-Romanelli, S; Walsh, K1
Balzi, M; Benvenuti, S; Cellai, I; Ceni, E; Deledda, C; Faraoni, P; Galli, A; Gelmini, S; Luciani, P; Peri, A; Petrangolini, G; Pratesi, G; Ricordati, C; Serio, M; Tortoreto, M1
Barañao, RI; Bilotas, M; Meresman, G; Olivares, C; Ricci, A1
El-Bouchtaoui, M; Gomez, D; Ho-Tin-Noé, B; Le Dall, J; Legrès, L; Louedec, L; Meilhac, O; Michel, JB; Vranckx, R1
Chen, P; Chow, HC; Fan, YY; Fu, JX; Huang, HW; Leung, AY; Li, BZ; Li, J; Liang, R; Liu, R; Zhang, H; Zhang, XH1
Chou, FP; Lin, TM; Ou, HC; Sheu, WH; Yang, CH1
Arora, S; Bracke, ME; Chatterji, S; DePass, AL; Dwarakanath, BS; Goel, S; Joshi, R; Kohli, E; Kumar, A; Manral, S; Parmar, VS; Ponnan, P; Prasad, AK; Priya, N; Raj, HG; Rawat, DS; Rohil, V; Saluja, D; Saso, L; Singh, P1

Reviews

1 review(s) available for rosiglitazone and Angiogenesis, Pathologic

ArticleYear
The Competence of 7,8-Diacetoxy-4-Methylcoumarin and Other Polyphenolic Acetates in Mitigating the Oxidative Stress and their Role in Angiogenesis.
    Current topics in medicinal chemistry, 2015, Volume: 15, Issue:2

    Topics: Coumarins; Enzyme-Linked Immunosorbent Assay; Humans; Neovascularization, Pathologic; Oxidative Stress; Polyphenols; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Thioredoxins; Vascular Endothelial Growth Factor A

2015

Trials

1 trial(s) available for rosiglitazone and Angiogenesis, Pathologic

ArticleYear
Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes.
    Acta diabetologica, 2009, Volume: 46, Issue:1

    Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cytokines; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Neovascularization, Pathologic; Patient Selection; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2009

Other Studies

12 other study(ies) available for rosiglitazone and Angiogenesis, Pathologic

ArticleYear
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy.
    BMC genomic data, 2022, 09-16, Volume: 23, Issue:1

    Topics: Adipokines; AMP-Activated Protein Kinases; Angiogenesis Inhibitors; Computational Biology; Humans; Neovascularization, Pathologic; PPAR gamma; RNA, Messenger; Rosiglitazone; Triple Negative Breast Neoplasms

2022
Synergy between peroxisome proliferator-activated receptor γ agonist and radiotherapy in cancer.
    Cancer science, 2018, Volume: 109, Issue:7

    Topics: Animals; Chemoradiotherapy; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Microenvironment

2018
Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway.
    Molecular medicine reports, 2014, Volume: 10, Issue:1

    Topics: Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Down-Regulation; Humans; Ligands; Male; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphorylation; PPAR gamma; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Recombinant Proteins; Rosiglitazone; Signal Transduction; Thiazolidinediones; Vascular Endothelial Growth Factor A

2014
Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression.
    Molecular medicine reports, 2014, Volume: 10, Issue:4

    Topics: Cell Proliferation; Cell Survival; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Multiple Myeloma; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Cells, Cultured

2014
[Effect of rosiglitazone on the expression of HIF1α and IGF1 mRNA in myeloma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:7

    Topics: Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Multiple Myeloma; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; RNA, Messenger; Rosiglitazone; Thiazolidinediones

2014
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
    World journal of gastroenterology, 2009, Jan-28, Volume: 15, Issue:4

    Topics: Animals; Base Sequence; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; PPAR gamma; Prostaglandin D2; Retinoid X Receptor alpha; RNA, Messenger; RNA, Neoplasm; Rosiglitazone; Thiazolidinediones; Transplantation, Heterologous; Tretinoin; Vascular Endothelial Growth Factor A

2009
Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:1

    Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Diabetic Retinopathy; Hypoglycemic Agents; Ischemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Pioglitazone; Retinal Vessels; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2010
In vivo effects of rosiglitazone in a human neuroblastoma xenograft.
    British journal of cancer, 2010, Feb-16, Volume: 102, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neovascularization, Pathologic; Neuroblastoma; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Tumor Burden; Xenograft Model Antitumor Assays

2010
The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.
    Fertility and sterility, 2011, Volume: 96, Issue:2

    Topics: Analysis of Variance; Animals; Antigens, CD34; Apoptosis; Celecoxib; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; PPAR gamma; Proliferating Cell Nuclear Antigen; Pyrazoles; Rosiglitazone; Sulfonamides; Thiazolidinediones; Time Factors; Uterus

2011
Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner.
    Circulation research, 2011, Oct-14, Volume: 109, Issue:9

    Topics: Anilides; Aorta; Cells, Cultured; Humans; Lipid Metabolism; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Plaque, Atherosclerotic; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A

2011
[Influence of rosiglitazone and all-trans-retinoic acid on angiogenesis and growth of myeloma xenograft in nude mice].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:9

    Topics: Animals; Antigens, CD34; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Multiple Myeloma; Neoplasm Transplantation; Neovascularization, Pathologic; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tretinoin; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012
Rosiglitazone inhibits endothelial proliferation and angiogenesis.
    Life sciences, 2006, Feb-23, Volume: 78, Issue:13

    Topics: Cell Division; Cell Survival; Cells, Cultured; DNA Replication; Endothelium, Vascular; Humans; Neovascularization, Pathologic; Rosiglitazone; Thiazolidinediones; Thymidine; Umbilical Veins; Vasodilator Agents

2006